| Autor: |
de Souza Souto JJ; Department of Psychology, Federal University of Paraíba, João Pessoa, Brazil., Edite Casé de Oliveira M; Department of Psychology, Federal University of Paraíba, João Pessoa, Brazil., Silva GM; Department of Psychology, Federal University of Paraíba, João Pessoa, Brazil., Nascimento de Sousa JM; Department of Psychology, Federal University of Paraíba, João Pessoa, Brazil., Fernandes Franco CI; Department of Physiotherapy, State University of Paraíba, João Pessoa, Brazil., Dos Santos NA; Department of Psychology, Federal University of Paraíba, João Pessoa, Brazil. |
| Jazyk: |
angličtina |
| Zdroj: |
Applied neuropsychology. Adult [Appl Neuropsychol Adult] 2024 Jul 05, pp. 1-11. Date of Electronic Publication: 2024 Jul 05. |
| DOI: |
10.1080/23279095.2024.2367108 |
| Abstrakt: |
Parkinson's disease is the second most common neurodegenerative disease, but therapeutic options such as neuromodulation continue to show variable effects, making clinical management of the disease difficult. This systematic review with meta-analysis and meta-regression aimed to analyze the isolated effect of cortical modulation with transcranial direct current stimulation (tDCS) compared to sham stimulation on cognitive changes in people with Parkinson's disease. The databases used were: Web of Science, Scopus, PsycINFO, PubMed, and Cochrane. The results showed that tDCS can influence the improvement of cognition in PD (Inverse Variance:0.24 [95% Confidence Interval: 0.09 to -0.40], p < 0.00). The meta-analysis showed that active tDCS can influence cognitive function by improving aspects related to memory (Inverse Variance:0.34 [95% Confidence Interval: 0.07 to 0.61], p < 0.01) and reducing reaction time in cognitive tasks (Inverse Variance:0.42 [95% Confidence Interval: 0.07 to 0.76], p < 0.02). Innovative meta-regression analyses showed that variables such as age (Q = 2.54, df = 1, p < 0.11), education level (Q = 2.62, df = 1, p < 0.10), disease duration (Q = 0.01, df = 1, p < 0.92), and Unified PD Rating Scale stage (Q = 0.01, df = 1, p < 0.92) did not influence the results. Thus, tDCS may be a therapeutic option for cognitive changes in people with PD, and we suggest further studies to identify protocols that can be replicated. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
